These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24449025)

  • 1. In vivo toxicity and biodistribution of intraperitoneal and intravenous poly-L-lysine and poly-L-lysine/poly-L-glutamate in rats.
    Isaksson K; Akerberg D; Posaric-Bauden M; Andersson R; Tingstedt B
    J Mater Sci Mater Med; 2014 May; 25(5):1293-9. PubMed ID: 24449025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and dose response of intra-abdominally administered poly-L-alpha-lysine and poly-L-glutamate for postoperative adhesion protection.
    Isaksson K; Akerberg D; Andersson R; Tingstedt B
    Eur Surg Res; 2010; 44(1):17-22. PubMed ID: 19923842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.
    Panagi Z; Beletsi A; Evangelatos G; Livaniou E; Ithakissios DS; Avgoustakis K
    Int J Pharm; 2001 Jun; 221(1-2):143-52. PubMed ID: 11397575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days.
    Navarro SM; Morgan TW; Astete CE; Stout RW; Coulon D; Mottram P; Sabliov CM
    Nanomedicine (Lond); 2016 Jul; 11(13):1653-69. PubMed ID: 27347781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of biodegradable microspheres injected into rat brain.
    Nicholas AP; McInnis C; Gupta KB; Snow WW; Love DF; Mason DW; Ferrell TM; Staas JK; Tice TR
    Neurosci Lett; 2002 Apr; 323(2):85-8. PubMed ID: 11950499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducing a change in the pharmacokinetics and biodistribution of poly-L-lysine in rats by complexation with heparin.
    Johnston TP; Kuchimanchi KR; Alur H; Chittchang M; Mitra AK
    J Pharm Pharmacol; 2003 Aug; 55(8):1083-90. PubMed ID: 12956897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
    Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis SS; Garnett MC; Davies MC; Illum L
    Biomaterials; 1997 Sep; 18(17):1147-52. PubMed ID: 9259511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
    Saez A; Guzmán M; Molpeceres J; Aberturas MR
    Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles.
    Aragao-Santiago L; Hillaireau H; Grabowski N; Mura S; Nascimento TL; Dufort S; Coll JL; Tsapis N; Fattal E
    Nanotoxicology; 2016; 10(3):292-302. PubMed ID: 26573338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
    Kohane DS; Lipp M; Kinney RC; Anthony DC; Louis DN; Lotan N; Langer R
    J Biomed Mater Res; 2002 Mar; 59(3):450-9. PubMed ID: 11774302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres.
    Roullin VG; Deverre JR; Lemaire L; Hindré F; Venier-Julienne MC; Vienet R; Benoit JP
    Eur J Pharm Biopharm; 2002 May; 53(3):293-9. PubMed ID: 11976017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
    Simon LC; Sabliov CM
    Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body distribution of poly(D,L-lactide-co-glycolide) copolymer degradation products in rats.
    Hua N; Sun J
    J Mater Sci Mater Med; 2008 Oct; 19(10):3243-8. PubMed ID: 18470703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
    Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
    J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.
    Yu Y; Pang Z; Lu W; Yin Q; Gao H; Jiang X
    Pharm Res; 2012 Jan; 29(1):83-96. PubMed ID: 21979908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles.
    Avgoustakis K; Beletsi A; Panagi Z; Klepetsanis P; Livaniou E; Evangelatos G; Ithakissios DS
    Int J Pharm; 2003 Jun; 259(1-2):115-27. PubMed ID: 12787641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pleural adhesions by bioactive polypeptides - a pilot study.
    Åkerberg D; Posaric-Bauden M; Isaksson K; Andersson R; Tingstedt B
    Int J Med Sci; 2013; 10(12):1720-6. PubMed ID: 24151443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
    Duan Y; Sun X; Gong T; Wang Q; Zhang Z
    J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content.
    Li M; Panagi Z; Avgoustakis K; Reineke J
    Int J Nanomedicine; 2012; 7():1345-56. PubMed ID: 22419876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
    Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
    Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.